Neurona will kick start a Phase III trial in H2 2025 investigating NRTX-1001 in patients with a type of drug-resistant ...

Researchers have found that an FDA-approved arthritis drug suppresses seizures and improves memory, offering new hope for a ...

A real-world study supports cenobamate as an effective option for patients with drug-resistant epilepsy even after multiple ...

Both add-on therapy and substitution monotherapy are equally effective as second-line treatments for women with idiopathic ...

According to the latest research study, the global epilepsy treatment devices market was valued at approximately USD 526.8 Million in 2023 and is expected to reach a value of around USD 787.3 Million ...

This article is authored by Dr Amit Kumar Agarwal, senior consultant, neurosciences, neurology and stroke medicine, Amrita ...

A Chilliwack mother faces a year-and-a-half wait for an epilepsy procedure. The hospital that performs them, VGH, can only do ...

Epilepsy is a long-term (chronic) disease that causes repeated seizures due to abnormal electrical signals produced by ...